Navidea Biopharmaceuticals logo
Navidea Biopharmaceuticals NAVB
$ 0.08 -2.99%

Quarterly report 2023-Q3
added 11-14-2023

report update icon

Navidea Biopharmaceuticals Income Statement 2011-2024 | NAVB

Annual Income Statement Navidea Biopharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

8.96 M 28.5 M 52.1 M 17.4 M 22.2 M 58.2 M 69.9 M 125 M 239 M 211 M 315 M 248 M

Shares

30.9 M 29.3 M 23.9 M 14.4 M 8.53 M 8.08 M 7.77 M 7.56 M 7.44 M 6.09 M 4.95 M 4.53 M

Historical Prices

0.29 0.97 2.18 1.2 3.2 7.2 11 16.6 32.2 35.2 65.8 54

Net Income

-15.2 M -11.7 M -10.7 M -10.9 M -16.1 M 74.9 M -14.3 M -27.6 M -35.7 M -42.7 M -29.2 M 5.61 M

Revenue

65.7 K 532 K 915 K 658 K 1.17 M 1.81 M 22 M 13.2 M 6.27 M 1.13 M 78.7 K 598 K

Cost of Revenue

1.94 K - 1.05 K 6.67 K 96.6 K 3.65 K - - - - - -

Gross Profit

-119 K 532 K 914 K 651 K 1.07 M 1.81 M 19.7 M 11.5 M 4.69 M 798 K 78.7 K 598 K

Operating Income

-14.1 M -12.1 M -10.7 M -11 M -10.8 M -13.9 M -10.1 M -18.4 M -22.6 M -38.4 M -28 M -24.1 M

Interest Expense

-27.9 K -14.1 K -21.9 K -7.61 K 1.14 K -33.3 K -27.9 K 26.8 K 3.71 M 2.78 M 1.17 M 13.3 K

EBITDA

-14 M -12 M -10.6 M -10.8 M -10.7 M -13.6 M -1.72 M -18 M -27.1 M -38 M -27.8 M -23.9 M

Operating Expenses

13.9 M 12.6 M 11.6 M 11.6 M 11.9 M 15.7 M 21.9 M 30 M 32.3 M 39.2 M 28.1 M 24.7 M

General and Administrative Expenses

7.96 M 7.45 M 6.69 M 6.28 M 7.7 M 11.2 M 13 M 17.3 M 15.5 M 15.5 M 11.2 M 9.55 M

All numbers in USD currency

Quarterly Income Statement Navidea Biopharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

99.4 M 48.2 M 32.7 M 32.7 M 30.7 M 30.3 M 30.2 M 30.3 M 30.1 M 29.1 M 28.1 M 27.1 M 25.8 M 22.8 M 20.2 M 19.2 M 18 M 11.1 M 10 M 10 M 167 M 163 M 8.11 M 162 M 162 M 162 M 160 M 156 M 155 M 155 M 155 M 156 M 150 M 150 M 150 M 150 M 150 M 150 M 145 M 136 M 121 M 118 M 114 M 113 M 102 M 94.7 M 94.1 M 95.4 M 93.1 M 89.7 M 95.4 M

Net Income

-2.26 M 6.03 M -1.48 M - -5.71 M -3 M -2.99 M - -2.44 M -2.67 M -2.97 M - -2.9 M -2.33 M -2.67 M - -3.07 M -2.67 M -2.43 M - -3.82 M -2.39 M -6.74 M -4.06 M -1.39 M -5.19 M 85.6 M -3.88 M -59.4 K -6.68 M -3.69 M -2.51 M -8.07 M -9.69 M -7.29 M -6.86 M -6.9 M -10.2 M -11.7 M -13.8 M -11.3 M -10.3 M -7.34 M -7.2 M -9.1 M -5.83 M -6.99 M - 19.8 M -2.19 M -4.42 M

Revenue

- - - - 7.52 K 57.5 K - - 96.4 K 261 K 124 K - 268 K 271 K 156 K - 237 K 260 K 41.6 K - 231 K 542 K 276 K - 224 K 612 K 580 K - 1.82 M 1.17 M 948 K - 3.98 M 1.96 M 1.84 M 1.46 M 1.1 M 1.05 M 627 K 343 K 144 K 128 K - - - - - - 256 K 3.16 M -

Cost of Revenue

- - - - 1.43 K 473 - - - - - - 82 357 609 - 195 238 6.13 K - 38.1 K 35.4 K 318 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - -127 K 57.1 K - - 96.4 K 261 K 124 K - 268 K 271 K 156 K - 237 K 260 K 35.5 K - 193 K 507 K 276 K 391 K 224 K 612 K 580 K 975 K 1.82 M 1.17 M 947 K 796 K 1.03 M 904 K 276 K 1.88 M 1.44 M 804 K 559 K 383 K 325 K 90 K - 7 K - 60 K 12 K - - 2.19 M -

Operating Income

-2.13 M -2.43 M -2.42 M - -4.95 M -2.92 M -2.98 M - -2.42 M -2.67 M -3.33 M - -2.9 M -2.34 M -2.67 M - -3.08 M -2.67 M -2.43 M - -3.72 M -2.43 M -2.5 M -3.52 M -2.39 M -4.82 M -3.15 M -3.24 M -910 K -2.24 M -3.76 M -3.46 M -4.91 M -3.44 M -6.62 M -4.48 M -5.36 M -9.22 M -8.58 M -13.1 M -9.92 M -8.46 M -7 M -7.03 M -9.07 M -5.39 M -6.51 M - -6.47 M -3.59 M -5 M

Interest Expense

-21.5 K -145 K -17.2 K - 8.42 K 6.73 K -4.3 K - 2.8 K -5.69 K -255 - -564 -336 124 - -1.52 K -3.22 K -1.14 K - 3.54 K 2.83 K -4.71 K - -6.98 K -16.7 K -21.6 K - -12.5 K -126 -37.3 K - 4.4 K -4.83 K 26.5 K - 921 K 914 K 944 K - 976 K 465 K 363 K - 315 K 321 K 294 K - 564 1.06 K 1.61 K

EBITDA

-2.1 M -2.4 M -2.39 M - -4.93 M -2.9 M -2.96 M - -2.37 M -2.63 M -3.31 M - -2.85 M -2.3 M -2.65 M - -2.98 M -2.6 M -2.4 M - -3.61 M -2.35 M -2.46 M -3.52 M -2.17 M -4.66 M -3.06 M -3.24 M -531 K -1.97 M -3.61 M -3.46 M -4.78 M -3.29 M -6.47 M -4.48 M -5 M -8.98 M -8.47 M -13.1 M -9.6 M -8.22 M -6.93 M -7.03 M -8.93 M -5.3 M -6.47 M - -6.32 M -3.48 M -4.94 M

Operating Expenses

2.13 M 2.43 M 2.42 M - 4.82 M 2.98 M 2.98 M - 2.52 M 2.93 M 3.45 M - 3.17 M 2.61 M 2.83 M - 3.32 M 2.93 M 2.47 M - 3.91 M 2.93 M 2.78 M 3.91 M 2.61 M 5.44 M 3.73 M 4.22 M 2.73 M 3.41 M 4.7 M 4.26 M 5.95 M 4.35 M 6.9 M 6.36 M 6.8 M 10 M 9.14 M 13.4 M 10.2 M 8.55 M 7 M 7.03 M 9.07 M 5.45 M 6.52 M - 6.73 M 3.59 M 5.34 M

General and Administrative Expenses

1.3 M 1.32 M 1.15 M - 3.64 M 1.26 M 1.81 M - 1.47 M 1.43 M 2.23 M - 1.79 M 1.33 M 1.83 M - 1.52 M 1.86 M 1.73 M - 2.69 M 1.79 M 1.78 M - 1.73 M 4.25 M 3.02 M - 1.81 M 1.39 M 2.63 M - 3.94 M 4.05 M 5.49 M - 2.65 M 4.91 M 3.91 M - 3.97 M 4.17 M 3.36 M - 2.94 M 2.97 M 2.57 M - 2.87 M 1.73 M 2.9 M

All numbers in USD currency